特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959889

リキッドバイオプシーの世界市場 (循環バイオマーカー・製品・アプリケーション・エンドユーザー・臨床アプリケーション・癌の種類・サンプルタイプ):イニシアチブ・資金・主要契約・企業プロファイル・近年の発展動向 (2027年までの予測)

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, & Others), Initiatives, Funding, Major Deals, 35 Company Profiles & Recent Developments-Forecast to 2027

出版日: | 発行: iGate Research Pvt Ltd | ページ情報: 英文 472 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
リキッドバイオプシーの世界市場 (循環バイオマーカー・製品・アプリケーション・エンドユーザー・臨床アプリケーション・癌の種類・サンプルタイプ):イニシアチブ・資金・主要契約・企業プロファイル・近年の発展動向 (2027年までの予測)
出版日: 2020年09月10日
発行: iGate Research Pvt Ltd
ページ情報: 英文 472 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界におけるリキッドバイオプシーの市場規模は、2027年までに約82億米ドルに達すると予測されています。リキッドバイオプシーは、費用のかかる、または侵襲的な処置を必要とせずに、液体サンプルを使用して分子バイオマーカーを検出する非侵襲的な技術です。

固形腫瘍生検に対するリキッドバイオプシー (液体生検) の利点、癌の有病率の上昇、非侵襲的処置への選好の増加、リキッドバイオプシーの分野における研究活動を支援するための公的資金と民間資金の増加、および政府のイニシアチブは、今後数年間でリキッドバイオプシー市場の成長を促進する見込みです。リキッドバイオプシー市場の成長を阻害する主な要因には、臨床的有用性の課題、リキッドバイオプシー検査の感度と特異性の欠如、不明確な医療費償還と規制のシナリオなどがあります。

当レポートでは、世界のリキッドバイオプシー市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域・国別の市場分析、競合情勢などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 COVID-19が世界のリキッドバイオプシー市場に与える影響

第3章 世界のリキッドバイオプシー:市場・予測

第4章 世界のリキッドバイオプシー:市場シェア・予測

  • 循環バイオマーカー別
  • 製品別
  • アプリケーション別
  • 臨床アプリケーション別
  • 癌の種類別
  • エンドユーザー別
  • サンプルタイプ別
  • 地域分析
  • 各国分析

第5章 世界のリキッドバイオプシー市場&予測:循環バイオマーカー

  • 循環腫瘍細胞(CTC)市場&予測
  • 循環腫瘍DNA(ctDNA)市場&予測
  • セルフリーDNA(cfDNA)市場&予測
  • 細胞外小胞(EV)市場&予測
  • その他の循環バイオマーカー市場&予測

第6章 世界のリキッドバイオプシー市場&予測:製品別

  • キット&消耗品市場と予測
  • 装置市場&予測
  • サービス市場&予測

第7章 世界のリキッドバイオプシー市場&予測:アプリケーション別

  • 腫瘍学アプリケーション市場&予測
  • 腫瘍学市場&予測:癌の種類別
    • 肺癌
    • 乳癌
    • 大腸癌
    • 前立腺癌
    • 消化器癌
    • 白血病
    • その他
  • 非癌アプリケーション市場&予測

第8章 世界のリキッドバイオプシー腫瘍学市場&予測:臨床アプリケーション別

  • 治療選択市場&予測
  • 治療モニタリング市場&予測
  • 早期癌検診市場&予測
  • 再発モニタリング市場&予測

第9章 世界のリキッドバイオプシー市場&予測:エンドユーザー別

  • リファレンスラボ市場&予測
  • 病院&開業医市場&予測
  • 大学&研究センター市場&予測
  • その他のエンドユーザー市場&予測

第10章 世界のリキッドバイオプシー市場&予測:サンプルタイプ別

  • 血液サンプル市場&予測
  • 尿サンプル市場&予測
  • その他の液体サンプル市場&予測

第11章 世界のリキッドバイオプシー市場&予測:地域分析

  • 北米
  • アジア太平洋
  • 欧州
  • ラテンアメリカ
  • 中東・アフリカ

第12章 リキッドバイオプシー市場シェア&予測:地域分析

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 韓国
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • 中東・アフリカ
    • UAE
    • サウジアラビア
    • エジプト
    • その他中東およびアフリカ
  • ラテンアメリカ

第13章 リキッドバイオプシーのイニシアチブ

第14章 リキッドバイオプシー企業の資金詳細

第15章 企業プロファイル

  • Personal Genome Diagnostics
  • Guardant Health、Inc.
  • Pathway Genomics
  • RainDance Technologies(Bio-Rad Laboratories、Inc. が買収)
  • Cardiff Oncology (Previously Trovagene, Inc.)
  • LungLife AI(旧 Cynvenio Biosystems、Inc.)
  • Biocept, Inc.
  • ANGLE plc
  • MDxHealth
  • Biolidics Limited(旧 Clearbridge Biomedics Pte Ltd)
  • Exosome Diagnostics、Inc.(Bio-Techne Corporation により買収)
  • Foundation Medicine、Inc.
  • Roche Diagnostics(F. Hoffmann-La Roche AG の子企業)
  • Genomic Health(現、Exact Sciences Corp の一部)
  • Myriad Genetics、Inc.
  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • Bio-Rad Laboratories, Inc.
  • Menarini-Silicon Biosystems
  • GRAIL
  • NeoGenomics、Inc.
  • DiaCarta、Inc.
  • OncoCell MDx(現、Immunis.AI)
  • C2i Genomics
  • Biodesix
  • Freenome
  • Inivata
  • CellMax Life
  • Rarecyte Inc.
  • Saga Diagnostics
  • Thrive Earlier Detection Corp.
  • Lucence Diagnostics Pte Ltd
  • Karius, Inc.
  • Clinical Genomics Technologies Pty Ltd(CG)
  • Elypta

第16章 世界のリキッドバイオプシー市場:推進要因

  • リキッドバイオプシー市場の拡大が見込まれるリキッドバイオプシーの用途拡大
  • 臨床診療におけるリキッドバイオプシーテストの利用を促進する個別化医療
  • リキッドバイオプシー市場を推進するための高齢者人口の増加と癌発生率の上昇
  • 新しいリキッドバイオプシー製品が市場収益を拡大
  • 癌検出を改善するための政府資金がリキッドバイオプシー市場の成長を後押し
  • リキッドバイオプシー市場の成長を強化するためのコラボレーションを通じた研究開発における製造業者の焦点の増加

第17章 世界のリキッドバイオプシー市場:課題

  • リキッドバイオプシー市場を制限するためのサードパーティ保険者のカバレッジの制限
  • リキッドバイオプシー臨床ユーティリティの課題
  • リキッドバイオプシー用の検査室開発テスト(LDT)に関する不明確な規制
図表

List of Figures:

  • Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
  • Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
  • Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2015 - 2019
  • Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2020 - 2027
  • Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2015 - 2019
  • Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2020 - 2027
  • Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2015 - 2019
  • Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2020 - 2027
  • Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (Evs) Market (Million US$), 2015 - 2019
  • Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (Evs) Market (Million US$), 2020 - 2027
  • Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2015 - 2019
  • Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2020 - 2027
  • Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2015 - 2019
  • Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2020 - 2027
  • Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2015 - 2019
  • Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2020 - 2027
  • Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2015 - 2019
  • Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2020 - 2027
  • Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2015 - 2019
  • Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2020 - 2027
  • Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2015 - 2019
  • Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2020 - 2027
  • Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2015 - 2019
  • Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2020 - 2027
  • Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2015 - 2019
  • Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2020 - 2027
  • Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2015 - 2019
  • Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2020 - 2027
  • Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2015 - 2019
  • Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2020 - 2027
  • Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2015 - 2019
  • Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2020 - 2027
  • Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2015 - 2019
  • Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2020 - 2027
  • Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2015 - 2019
  • Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2020 - 2027
  • Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2015 - 2019
  • Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2020 - 2027
  • Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2015 - 2019
  • Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2020 - 2027
  • Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2015 - 2019
  • Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2020 - 2027
  • Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2015 - 2019
  • Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2020 - 2027
  • Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-9: China - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-11: India - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-19: France - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027

List of Tables:

  • Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
  • Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
  • Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions
目次

Title:
Global Liquid Biopsy Market
(by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027.

The global liquid biopsy market is expected to reach nearly US$ 8.2 Billion by 2027. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. Liquid biopsy aids in planning the required treatment and also check for treatment effectiveness as well as repeated occurrence of tumor during and after the course of cancer treatment. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Recent Developments

  • In June 2020, NeoGenomics, Inc. announced the launch of three liquid biopsy tests for advanced non-small cell lung cancer, all solid tumor types (pan-cancer), and certain breast cancer cases.
  • In June 2020, Guardant Health presented new data demonstrating that its LUNAR-2 liquid biopsy is a highly sensitive test that can detect early-stage colorectal cancer.
  • In January 2020, Personal Genome Diagnostics Inc. partnered with Eisai Co., Ltd. To develop a comprehensive liquid biopsy biomarker discovery solution for oncology
  • In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding.
  • In June 2019, Saga Diagnostics, a Lund, Sweden based company raised US$ 4.1 Million in a financing round from Hadean Ventures.
  • In February 2019, MDxHealth SA signed an exclusive distribution agreement with LifeLabs to make SelectMDx, the Company's non-invasive liquid biopsy prostate cancer test, available in Canada
  • In August 2018, Bio-Techne Corporation completed its acquisition of Exosome Diagnostics, Inc.

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

  • Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).
  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.
  • The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.
  • The extracellular vesicles (Evs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast - by Product

  • The global liquid biopsy market, by product, is being dominated by Kits and Consumables.
  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.
  • The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by Application

  • The global liquid biopsy market, by application, is being dominated by oncology application.
  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.
  • Treatment monitoring captured second highest share of the liquid biopsy market in 2019, being followed by the early cancer screening application.
  • Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by End User

  • In 2019, Reference laboratories captured largest share of the global liquid biopsy market.
  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2019, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast - by Sample Type

  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.

Liquid Biopsy Market & Forecast - Regional Analysis

  • North America accounted for largest share of the global liquid biopsy market in 2019, followed by Asia Pacific.
  • In North America, United States accounted for largest share of the liquid biopsy market.
  • In Europe, Germany and France are the leading market for liquid biopsy.
  • Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecast period.
  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.
  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

iGATE RESEARCH, report titled "Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027" provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 472 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints:

1. Global Liquid Biopsy Market & Forecast (2015 - 2027)

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market Share & Forecast (2015 - 2027)

4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027)

5. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027)

6. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027)

7. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2015 - 2027)

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027)

9. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027)

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)

11. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027)

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027)

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. 35 Company Profiles - Recent Developments / Initiatives, Major Deals

16. Global Liquid Biopsy Market - Driving Factors & Challenges

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Cell-Free DNA (cfDNA)

4. Extracellular Vesicles (Evs)

5. Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast - by Product

1. Kits and Consumables

2. Instruments

3. Services

Global Liquid Biopsy Market & Forecast - by Application

1. Oncology Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Leukaemia
  • Others

2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring

Global Liquid Biopsy Market & Forecast - by End User

1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users

Global Liquid Biopsy Market & Forecast - by Sample Type

1. Blood Sample

2. Urine Sample

3. Other Fluids Sample

Liquid Biopsy Market & Forecast - Regional Analysis

1. North America

  • United States
  • Canada

2. Asia Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

3. Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

4. Middle East & Africa

  • UAE
  • Saudi Arabia
  • Egypt
  • Rest of Middle East & Africa

5. Latin America

Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals

1. Personal Genome Diagnostics

2. Guardant Health, Inc.

3. Pathway Genomics

4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

5. Cardiff Oncology (Previously Trovagene, Inc.)

6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

12. Foundation Medicine, Inc

13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14. Genomic Health (Now Part of Exact Sciences Corp)

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. Bio-Rad Laboratories, Inc

19. Menarini-Silicon Biosystems

20. GRAIL

21. NeoGenomics, Inc.

22. DiaCarta, Inc.

23. OncoCell MDx (Now Immunis.AI)

24. C2i Genomics

25. Biodesix

26. Freenome

27. Inivata

28. CellMax Life

29. Rarecyte Inc.

30. Saga Diagnostics

31. Thrive Earlier Detection Corp.

32. Lucence Diagnostics Pte Ltd

33. Karius, Inc.

34. Clinical Genomics Technologies Pty Ltd (CG)

35. Elypta

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market & Forecast (2015 - 2027)

4. Global Liquid Biopsy Market Share & Forecast (2015 - 2027)

  • 4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
  • 4.2 Global Liquid Biopsy Market Share & Forecast - by Product
  • 4.3 Global Liquid Biopsy Market Share & Forecast - by Application
  • 4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
  • 4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
  • 4.6 Global Liquid Biopsy Market Share & Forecast - by End User
  • 4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
  • 4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
  • 4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027)

  • 5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
  • 5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
  • 5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
  • 5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
  • 5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027)

  • 6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
  • 6.2 Global Liquid Biopsy - Instruments Market & Forecast
  • 6.3 Global Liquid Biopsy - Services Market & Forecast

7. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027)

  • 7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
  • 7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
    • 7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
    • 7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
    • 7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
    • 7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
    • 7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
    • 7.2.6 Leukaemia Liquid Biopsy Market & Forecast
    • 7.2.7 Others Liquid Biopsy Market & Forecast
  • 7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027)

  • 8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
  • 8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
  • 8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
  • 8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027)

  • 9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
  • 9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
  • 9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
  • 9.4 Global Liquid Biopsy - Other End Users Market & Forecast

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)

  • 10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
  • 10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
  • 10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

11. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027)

  • 11.1 North America Liquid Biopsy Market & Forecast
  • 11.2 Asia Pacific Liquid Biopsy Market & Forecast
  • 11.3 Europe Liquid Biopsy Market & Forecast
  • 11.4 Latin America Liquid Biopsy Market & Forecast
  • 11.5 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027)

  • 12.1 North America Liquid Biopsy Market & Forecast
    • 12.1.1 United States Liquid Biopsy Market & Forecast
    • 12.1.2 Canada Liquid Biopsy Market & Forecast
  • 12.2 Asia Pacific Liquid Biopsy Market & Forecast
    • 12.2.1 South Korea Liquid Biopsy Market & Forecast
    • 12.2.2 Japan Liquid Biopsy Market & Forecast
    • 12.2.3 China Liquid Biopsy Market & Forecast
    • 12.2.4 India Liquid Biopsy Market & Forecast
    • 12.2.5 Australia Liquid Biopsy Market & Forecast
    • 12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
  • 12.3 Europe Liquid Biopsy Market & Forecast
    • 12.3.1 Germany Liquid Biopsy Market & Forecast
    • 12.3.2 France Liquid Biopsy Market & Forecast
    • 12.3.3 United Kingdom Liquid Biopsy Market & Forecast
    • 12.3.4 Italy Liquid Biopsy Market & Forecast
    • 12.3.5 Spain Liquid Biopsy Market & Forecast
    • 12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
  • 12.4 Middle East & Africa Liquid Biopsy Market & Forecast
    • 12.4.1 UAE Liquid Biopsy Market & Forecast
    • 12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
    • 12.4.3 Egypt Liquid Biopsy Market & Forecast
    • 12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
  • 12.5 Latin America Liquid Biopsy Market & Forecast

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. Company Profiles

  • 15.1 Personal Genome Diagnostics
    • 15.1.1 Company Overview
    • 15.1.2 Recent Developments / Initiatives
  • 15.2 Guardant Health, Inc.
    • 15.2.1 Company Overview
    • 15.2.2 Recent Developments / Initiatives
  • 15.3 Pathway Genomics
    • 15.3.1 Company Overview
    • 15.3.2 Recent Developments / Initiatives
  • 15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
    • 15.4.1 Company Overview
    • 15.4.2 Recent Developments / Initiatives
  • 15.5 Cardiff Oncology (Previously Trovagene, Inc.)
    • 15.5.1 Company Overview
    • 15.5.2 Recent Developments / Initiatives
  • 15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.)
    • 15.6.1 Company Overview
    • 15.6.2 Recent Developments / Initiatives
  • 15.7 Biocept, Inc.
    • 15.7.1 Company Overview
    • 15.7.2 Recent Developments / Initiatives
  • 15.8 ANGLE plc
    • 15.8.1 Company Overview
    • 15.8.2 Recent Developments / Initiatives
  • 15.9 MDxHealth
    • 15.9.1 Company Overview
    • 15.9.2 Recent Developments / Initiatives
  • 15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
    • 15.10.1 Company Overview
    • 15.10.2 Recent Developments / Initiatives
  • 15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
    • 15.11.1 Company Overview
    • 15.11.2 Recent Developments / Initiatives
  • 15.12 Foundation Medicine, Inc.
    • 15.12.1 Company Overview
    • 15.12.2 Recent Developments / Initiatives
  • 15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
    • 15.13.1 Company Overview
    • 15.13.2 Recent Developments / Initiatives
  • 15.14 Genomic Health (Now Part of Exact Sciences Corp)
    • 15.14.1 Company Overview
    • 15.14.2 Recent Developments / Initiatives
  • 15.15 Myriad Genetics, Inc.
    • 15.15.1 Company Overview
    • 15.15.2 Recent Developments / Initiatives
  • 15.16 Thermo Fisher Scientific, Inc.
    • 15.16.1 Company Overview
    • 15.16.2 Recent Developments / Initiatives
  • 15.17 QIAGEN NV
    • 15.17.1 Company Overview
    • 15.17.2 Recent Developments / Initiatives
  • 15.18 Bio-Rad Laboratories, Inc.
    • 15.18.1 Company Overview
    • 15.18.2 Recent Developments / Initiatives
  • 15.19 Menarini-Silicon Biosystems
    • 15.19.1 Company Overview
    • 15.19.2 Recent Developments / Initiatives
  • 15.20 GRAIL
    • 15.20.1 Company Overview
    • 15.20.2 Recent Developments / Initiatives
  • 15.21 NeoGenomics, Inc.
    • 15.21.1 Company Overview
    • 15.21.2 Recent Developments / Initiatives
  • 15.22 DiaCarta, Inc.
    • 15.22.1 Company Overview
    • 15.22.2 Recent Developments / Initiatives
  • 15.23 OncoCell MDx (Now Immunis.AI)
    • 15.23.1 Company Overview
    • 15.23.2 Recent Developments / Initiatives
  • 15.24 C2i Genomics
    • 15.24.1 Company Overview
  • 15.25 Biodesix
    • 15.25.1 Company Overview
    • 15.25.2 Recent Developments / Initiatives
  • 15.26 Freenome
    • 15.26.1 Company Overview
    • 15.26.2 Recent Developments / Initiatives
  • 15.27 Inivata
    • 15.27.1 Company Overview
    • 15.27.2 Recent Developments / Initiatives
  • 15.28 CellMax Life
    • 15.28.1 Company Overview
    • 15.28.2 Recent Developments / Initiatives
  • 15.29 Rarecyte Inc.
    • 15.29.1 Company Overview
    • 15.29.2 Recent Developments / Initiatives
  • 15.30 Saga Diagnostics
    • 15.30.1 Company Overview
    • 15.30.2 Recent Developments / Initiatives
  • 15.31 Thrive Earlier Detection Corp.
    • 15.31.1 Company Overview
    • 15.31.2 Recent Developments / Initiatives
  • 15.32 Lucence Diagnostics Pte Ltd
    • 15.32.1 Company Overview
    • 15.32.2 Recent Developments / Initiatives
  • 15.33 Karius, Inc.
    • 15.33.1 Company Overview
    • 15.33.2 Recent Developments / Initiatives
  • 15.34 Clinical Genomics Technologies Pty Ltd (CG)
    • 15.34.1 Company Overview
    • 15.34.2 Recent Developments / Initiatives
  • 15.35 Elypta
    • 15.35.1 Company Overview
    • 15.35.2 Recent Developments / Initiatives

16. Global Liquid Biopsy Market - Driving Factors

  • 16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
  • 16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
  • 16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
  • 16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
  • 16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
  • 16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

17. Global Liquid Biopsy Market - Challenges

  • 17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
  • 17.2 Liquid Biopsy Clinical Utility Challenges
  • 17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.